Cargando…
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
The primary objective of the study was to evaluate the feasibility and safety of a process which would utilize genome-wide expression data from tumor biopsies to support individualized treatment decisions. Current treatment options for recurrent neuroblastoma are limited and ineffective, with a surv...
Autores principales: | Saulnier Sholler, Giselle L, Bond, Jeffrey P, Bergendahl, Genevieve, Dutta, Akshita, Dragon, Julie, Neville, Kathleen, Ferguson, William, Roberts, William, Eslin, Don, Kraveka, Jacqueline, Kaplan, Joel, Mitchell, Deanna, Parikh, Nehal, Merchant, Melinda, Ashikaga, Takamaru, Hanna, Gina, Lescault, Pamela Jean, Siniard, Ashley, Corneveaux, Jason, Huentelman, Matthew, Trent, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472210/ https://www.ncbi.nlm.nih.gov/pubmed/25720842 http://dx.doi.org/10.1002/cam4.436 |
Ejemplares similares
-
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
por: Saulnier Sholler, Giselle L., et al.
Publicado: (2015) -
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
por: Sholler, Giselle L. Saulnier, et al.
Publicado: (2018) -
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma
por: Lewis, Elizabeth C., et al.
Publicado: (2020) -
A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma
por: Kraveka, Jacqueline M., et al.
Publicado: (2022) -
Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma
por: Cornelius, Albert, et al.
Publicado: (2017)